Leiv Ose

8.5k total citations
161 papers, 5.8k citations indexed

About

Leiv Ose is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Leiv Ose has authored 161 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Surgery, 43 papers in Cancer Research and 42 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Leiv Ose's work include Lipoproteins and Cardiovascular Health (98 papers), Cancer, Lipids, and Metabolism (40 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (33 papers). Leiv Ose is often cited by papers focused on Lipoproteins and Cardiovascular Health (98 papers), Cancer, Lipids, and Metabolism (40 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (33 papers). Leiv Ose collaborates with scholars based in Norway, United States and Netherlands. Leiv Ose's co-authors include Trond P. Leren, Kjetil Retterstøl, Serena Tonstad, Marit S. Nenseter, Kirsten B. Holven, Knut Erik Berge, Arne Svilaas, Bente Halvorsen, Brian W. McCrindle and Trond Berg and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Leiv Ose

159 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leiv Ose Norway 43 3.6k 1.6k 1.0k 910 866 161 5.8k
Jane Armitage United Kingdom 31 2.6k 0.7× 1.2k 0.8× 621 0.6× 1.2k 1.3× 807 0.9× 92 5.7k
Tamio Teramoto Japan 38 2.6k 0.7× 1.7k 1.1× 671 0.7× 1.5k 1.6× 878 1.0× 212 5.6k
Diane L. Tribble United States 34 2.9k 0.8× 2.0k 1.3× 997 1.0× 1.0k 1.2× 1.3k 1.5× 65 7.2k
Michael I. Mackness United Kingdom 42 2.7k 0.7× 2.6k 1.7× 471 0.5× 1.2k 1.3× 1.0k 1.2× 85 10.2k
R Peto United Kingdom 10 3.7k 1.0× 1.7k 1.1× 878 0.9× 1.5k 1.6× 394 0.5× 11 6.0k
Evan A. Stein United States 27 2.6k 0.7× 1.7k 1.1× 616 0.6× 818 0.9× 400 0.5× 59 4.7k
Brian A. Ference United States 29 3.6k 1.0× 2.0k 1.3× 862 0.9× 1.6k 1.7× 804 0.9× 67 6.4k
Ingmar Jungner Sweden 41 2.3k 0.6× 2.4k 1.5× 1.3k 1.3× 1.1k 1.3× 947 1.1× 107 6.1k
Evangelos Liberopoulos Greece 42 2.3k 0.6× 2.2k 1.4× 499 0.5× 1.1k 1.2× 937 1.1× 292 6.2k
Heinz Drexel Austria 40 4.2k 1.2× 2.6k 1.7× 927 0.9× 2.5k 2.8× 1.2k 1.4× 298 8.7k

Countries citing papers authored by Leiv Ose

Since Specialization
Citations

This map shows the geographic impact of Leiv Ose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiv Ose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiv Ose more than expected).

Fields of papers citing papers by Leiv Ose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leiv Ose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiv Ose. The network helps show where Leiv Ose may publish in the future.

Co-authorship network of co-authors of Leiv Ose

This figure shows the co-authorship network connecting the top 25 collaborators of Leiv Ose. A scholar is included among the top collaborators of Leiv Ose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leiv Ose. Leiv Ose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langslet, Gisle & Leiv Ose. (2013). Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia. Expert Review of Cardiovascular Therapy. 11(8). 1061–1066. 20 indexed citations
2.
Kusters, D. Meeike, Carine de Beaufort, Kurt Widhalm, et al.. (2011). Paediatric screening for hypercholesterolaemia in Europe: Table 1. Archives of Disease in Childhood. 97(3). 272–276. 61 indexed citations
3.
Svilaas, Arne, et al.. (2011). Kartlegging av kosthold og livsstil. Tidsskrift for Den norske legeforening. 131(5). 454–454. 3 indexed citations
4.
Holven, Kirsten B., Pål Aukrust, Kjetil Retterstøl, et al.. (2008). The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects. Journal of Nutrition. 138(11). 2070–2075. 26 indexed citations
5.
Håheim, Lise Lund, Atle Fretheim, Odd Brørs, et al.. (2008). Primary Prevention of Cardiovascular Disease, with Emphasis on Pharmacological Interventions. Europe PMC (PubMed Central). 1 indexed citations
6.
Feldman, Theodore, Leiv Ose, Arvind Shah, et al.. (2007). Efficacy and Safety of Ezetimibe/Simvastatin Versus Simvastatin Monotherapy in Hypercholesterolemic Patients with Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 5(1). 13–21. 6 indexed citations
7.
Amundsen, Ågot Lia, Janette Khoury, Per Ole Iversen, et al.. (2006). Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis. 189(2). 451–457. 90 indexed citations
8.
Fretheim, Atle, Arild Bjørndal, Andrew D Oxman, et al.. (2002). Hvilke kolesterolsenkende legemidler bør brukes for primærforebygging av hjerte- og karsykdommer?. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
9.
Fretheim, Atle, Arild Bjørndal, Andrew D Oxman, et al.. (2002). Retningslinjer for medikamentell primærforebygging av hjerte- og karsykdommer - hvem bør behandles?. Tidsskrift for Den Norske Laegeforening. 3 indexed citations
10.
Svilaas, Arne, et al.. (2000). Application of simple lipid treatment goals in patients with atherosclerotic disease.. PubMed. 10(2). 71–8. 1 indexed citations
11.
Tonstad, Serena, et al.. (2000). Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?. Acta Paediatrica. 89(12). 1490–1492. 15 indexed citations
12.
Crouse, John R., Jiří Fröhlich, Leiv Ose, Michele Mercuri, & Jonathan A. Tobert. (1999). Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. The American Journal of Cardiology. 83(10). 1476–1477. 112 indexed citations
13.
14.
Tonstad, Serena, Helga Refsum, M Sivertsen, et al.. (1996). Relation of Total Homocysteine and Lipid Levels in Children to Premature Cardiovascular Death in Male Relatives. Pediatric Research. 40(1). 47–52. 90 indexed citations
15.
Tonstad, Serena, Leiv Ose, Tor‐Arne Hagve, et al.. (1996). The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein(a) levels in familial hypercholesterolemia. Metabolism. 45(11). 1415–1421. 6 indexed citations
16.
Nenseter, Marit S., et al.. (1996). Effect of hormone replacement therapy on the susceptibility of low‐density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. European Journal of Clinical Investigation. 26(12). 1062–1068. 15 indexed citations
17.
18.
Leren, Trond P., et al.. (1993). Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene.. Genome Research. 3(3). 159–162. 36 indexed citations
19.
Grønn, Morten, et al.. (1991). Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: A controlled dietetic study. Scandinavian Journal of Clinical and Laboratory Investigation. 51(3). 255–263. 41 indexed citations
20.
Levin, L. Stefan, et al.. (1977). A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: Cranioectodermal dysplasia. The Journal of Pediatrics. 90(1). 55–61. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Armitage Breakdown of academic impact, for papers by Tamio Teramoto Breakdown of academic impact, for papers by Diane L. Tribble Breakdown of academic impact, for papers by Michael I. Mackness Breakdown of academic impact, for papers by R Peto Breakdown of academic impact, for papers by Evan A. Stein Breakdown of academic impact, for papers by Brian A. Ference Breakdown of academic impact, for papers by Ingmar Jungner Breakdown of academic impact, for papers by Evangelos Liberopoulos Breakdown of academic impact, for papers by Heinz Drexel
Rankless by CCL
2026